🇪🇺 Focetria® in European Union

EMA authorised Focetria® on 2 May 2007

Marketing authorisation

EMA — authorised 2 May 2007

  • Application: EMEA/H/C/000710
  • Marketing authorisation holder: Novartis Vaccines and Diagnostics S.r.l.
  • Local brand name: Focetria
  • Indication: Prophylaxis of influenza caused by A (H1N1v) 2009 virus. Focetria should be used in accordance with official guidance.
  • Status: withdrawn

Read official source →

Other Immunology / Infectious Disease approved in European Union

Frequently asked questions

Is Focetria® approved in European Union?

Yes. EMA authorised it on 2 May 2007.

Who is the marketing authorisation holder for Focetria® in European Union?

Novartis Vaccines and Diagnostics S.r.l. holds the EU marketing authorisation.